Research Intra-Cellular Therapies' (Nasdaq:ITCI) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth. Top 50 Inst. 5,, , 85,, Institutional Shareholder Style. Style, Holders, Value ($MM), % Inst Shares, Shares. View Intra-Cellular Therapies, Inc. ITCI stock quote prices, financial information, real-time forecasts, and company news from CNN. Based on 15 Wall Street analysts offering 12 month price targets for Intra-Cellular Therapies in the last 3 months. The average price target is $ with a. Intra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight following pipeline and regulatory updates, respectively.
Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs. The latest Intra-Cellular Therapies stock prices, stock quotes, news, and ITCI history to help you invest and trade smarter. Intra-Cellular Therapies stock down 22% after discontinuation of Phase 3 trial. Shares of Intra-Cellular Therapies Inc. plummeted 22% in pre-market trade. Intra-Cellular Therapies Inc. · AT CLOSE PM EDT 09/05/24 · USD · % · Volume, On Thursday, Intra-Cellular Therapies Inc (ITCI:NSQ) closed at , % below its week high of , set on Apr 16, week range. Today. Incyte Corp. $ INCY ; Axsome Therapeutics Inc. $ AXSM ; Advanced Micro Devices, Inc. $ AMD ; Sarepta Therapeutics Inc. $ SRPT ; NVIDIA. Our mission is to deliver innovative treatments to improve the lives of individuals with neuropsychiatric, neurologic, and other disorders. Intra-Cellular Therapies, Inc. (NasdaqGS:ITCI) institutional ownership structure shows current positions in the company by institutions and funds, as well as. Track Intra-Cellular Therapies Inc (ITCI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Discover real-time Intra-Cellular Therapies Inc. Common Stock (ITCI) stock prices, quotes, historical data, news, and Insights for informed trading and. Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs.
The current price of ITCI is USD — it has decreased by −% in the past 24 hours. Watch Intra-Cellular Therapies Inc. stock price performance more. Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs. Stock Information ; Previous Close; $ ; Open; $ ; Volume; 15, ; Exchange; NASDAQ ; 52 Week High; $ Intra-Cellular Therapies (ITCI) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering. Intra-Cellular Therapies Inc. · AT CLOSE PM EDT 09/05/24 · USD · % · Volume, Intra-Cellular Therapies Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Year End Stock Prices ; , ; , ; , ; , Intra-Cellular Therapies Inc ITCI ; Valuation · Price/Earnings (Normalized). —, , — ; Financial Strength · Quick Ratio. , , ; Profitability.
Intracellular Th News & Analysis · Intracellular Th receives Investment Bank Analyst Rating Update · Intra-Cellular Therapies executive sells over $m in stock. Intra-Cellular Therapies Inc ITCI:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date04/16/24 · 52 Week. Get Intra-Cellular Therapies Inc (ITCI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Intra-Cellular Therapies (ITCI) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Valuation: Intra-Cellular Therapies, Inc. ; P/E ratio * · EV / Sales * · Yield *.